Publications by authors named "Olaf Weber"

Claim this Profile
G
Gene editing of CD3 epsilon to redirect regulatory T cells for adoptive T cell transfer.
Weijie Du, Fatih Noyan, Oliver McCallion, Vanessa Drosdek, Jonas Kath, Olaf Weber

Mol Ther· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose Interleukin-2 Therapy: Fine-tuning Treg in Solid Organ Transplantation?
Leila Amini, Jaspal Kaeda, Olaf Weber, Petra Reinke

Transplantation· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity of Contrast-Enhanced Breast MRI vs X-ray Mammography Based on Cancer Histology, Tumor Grading, Receptor Status, and Molecular Subtype: A Supplemental Analysis of 2 Large Phase III Studies.
Jan Endrikat, Gilda Schmidt, Daniel Haverstock, Olaf Weber, Zuzana Jirakova Trnkova

Breast Cancer (Auckl)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does It Pay to Issue Green? An Institutional Comparison of Mainland China and Hong Kong's Stock Markets Toward Green Bonds.
Xingxing Chen, Olaf Weber, Vasundhara Saravade

Front Psychol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low kV Computed Tomography of Parenchymal Abdominal Organs-A Systematic Animal Study of Different Contrast Media Injection Protocols.
Daniel Overhoff, Gregor Jost, Michael McDermott, Olaf Weber, Hubertus Pietsch

Tomography· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic efficacy of contrast-enhanced breast MRI versus X-ray mammography in women with different degrees of breast density.
Jörg Barkhausen, Arpad Bischof, Daniel Haverstock, Mark Klemens, Guenther Brueggenwerth, Olaf Weber

Acta Radiol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inactivated Orf-virus shows disease modifying antiviral activity in a guinea pig model of genital herpesvirus infection.
Astrid Friebe, Angela Siegling, Olaf Weber

J Microbiol Immunol Infect· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AIC649 Induces a Bi-Phasic Treatment Response in the Woodchuck Model of Chronic Hepatitis B.
Daniela Paulsen, Olaf Weber, Helga Ruebsamen-Schaeff, Bud C Tennant, Stephan Menne

PLoS One· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inactivated ORF virus shows antifibrotic activity and inhibits human hepatitis B virus (HBV) and hepatitis C virus (HCV) replication in preclinical models.
Daniela Paulsen, Andreas Urban, Andreas Knorr, Claudia Hirth-Dietrich, Angela Siegling, Olaf Weber

PLoS One· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inactivated Orf virus (Parapoxvirus ovis) elicits antifibrotic activity in models of liver fibrosis.
Janina Nowatzky, Andreas Knorr, Claudia Hirth-Dietrich, Angela Siegling, Hans-Dieter Volk, Olaf Weber

Hepatol Res· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of a potentially effective dose in humans for BAY 60-5521, a potent inhibitor of cholesteryl ester transfer protein (CETP) by allometric species scaling and combined pharmacodynamic and physiologically-based pharmacokinetic modelling.
Olaf Weber, Stefan Willmann, Hilmar Bischoff, Volkhart Li, Alexandros Vakalopoulos

Br J Clin Pharmacol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single dose pharmacokinetics, pharmacodynamics, tolerability and safety of BAY 60-5521, a potent inhibitor of cholesteryl ester transfer protein.
Michael-Friedrich Boettcher, Roland Heinig, Carsten Schmeck, Christian Kohlsdorfer, Matthias Ludwig, Olaf Weber

Br J Clin Pharmacol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of type I interferon by splenic macrophages suppresses adaptive immunity during sepsis.
Timo Schwandt, Beatrix Schumak, Gerrit H Gielen, Frank Jüngerkes, Patricia Schmidbauer, Olaf Weber

EMBO J· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inactivated orf virus (Parapoxvirus ovis) induces antitumoral activity in transplantable tumor models.
Heinz-Herbert Fiebig, Angela Siegling, Hans-Dieter Volk, Astrid Friebe, Percy Knolle, Olaf Weber

Anticancer Res· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of immunostimulatory components of orf virus (parapoxvirus ovis).
Astrid Friebe, Sonja Friederichs, Kai Scholz, Uwe Janssen, Corinna Scholz, Olaf Weber

J Gen Virol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chromanol derivatives--a novel class of CETP inhibitors.
Alexandros Vakalopoulos, Carsten Schmeck, Michael Thutewohl, Volkhart Li, Hilmar Bischoff, Olaf Weber

Bioorg Med Chem Lett· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cholesteryl ester transfer protein and its inhibition.
Olaf Weber, Hilmar Bischoff, Carsten Schmeck, Michael-Friedrich Böttcher

Cell Mol Life Sci· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel tetrahydrochinoline derived CETP inhibitors.
Carsten Schmeck, Heike Gielen-Haertwig, Alexandros Vakalopoulos, Hilmar Bischoff, Volkhart Li, Olaf Weber

Bioorg Med Chem Lett· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KINK-1, a novel small-molecule inhibitor of IKKbeta, and the susceptibility of melanoma cells to antitumoral treatment.
Margarete Schön, B Gregor Wienrich, Susanne Kneitz, Helga Sennefelder, Katharina Amschler, Olaf Weber

J Natl Cancer Inst· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulatory effects of inactivated parapoxvirus ovis (ORF virus) on human peripheral immune cells: induction of cytokine secretion in monocytes and Th1-like cells.
Astrid Friebe, Angela Siegling, Sonja Friederichs, Hans-Dieter Volk, Olaf Weber

J Virol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inactivated parapoxvirus ovis (Orf virus) has antiviral activity against hepatitis B virus and herpes simplex virus.
Olaf Weber, Angela Siegling, Astrid Friebe, Andreas Limmer, Tobias Schlapp

J Gen Virol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids.
Karl Deres, Claus H Schröder, Arnold Paessens, Siegfried Goldmann, Hans Jörg Hacker, Olaf Weber

Science· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential calcium response in HeLa and HeLa-Fas cells by cytotoxic T lymphocytes.
E Marion Schneider, Ina Menzl, Olaf Weber, Hubert Hug

Biochem Biophys Res Commun· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease.
Gerald Kleymann, Rüdiger Fischer, Ulrich A K Betz, Martin Hendrix, Wolfgang Bender, Olaf Weber

Nat Med· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis